Expanding non-invasive prenatal testing beyond chromosomes 21, 18, 13, X and Y

Clinical Genetics

Volumn 90, Issue 6, 2016, Pages 477-485

  Benn, P ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

aneuploidy; cell free DNA; DNA copy number variations; microdeletions; non invasive testing; prenatal screening

Indexed keywords

DNA;

AMNIOCENTESIS; CHORION VILLUS SAMPLING; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME ABERRATION; CLINICAL PRACTICE; CYTOGENETICS; FOLLOW UP; GENETIC COUNSELING; HUMAN; LABORATORY TEST; MATERNAL PLASMA; MOSAICISM; NON INVASIVE PRENATAL TESTING; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; SEX CHROMOSOME ABERRATION; TRISOMY 13; TRISOMY 18; TRISOMY 21; VALIDATION STUDY; X CHROMOSOME; Y CHROMOSOME; CELL FREE SYSTEM; CHROMOSOME DISORDERS; FEMALE; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; PATHOLOGY; PRENATAL DIAGNOSIS; PROCEDURES; TRISOMY;

CELL-FREE SYSTEM; CHORIONIC VILLI SAMPLING; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; FEMALE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PRENATAL DIAGNOSIS; TRISOMY;

EID: 84978997781     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12818     Document Type: Review

References (77)

1. Cuckle H, Benn P, Pergament E. Cell-free DNA screening for fetal aneuploidy as a clinical service. Clin Biochem 2015: 48: 932–941.
2. Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015: 45: 249–266.
3. Norton ME, Jacobsson B, Swamy GK et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015: 372: 1589–1597.
4. Dar P, Curnow KJ, Gross SJ et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 2014: 211: 527 e521–527 e517.
5. Zhang H, Gao Y, Jiang F et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol 2015: 45: 530–538.
6. Guex N, Iseli C, Syngelaki A et al. A robust second-generation genome-wide test for fetal aneuploidy based on shotgun sequencing cell-free DNA in maternal blood. Prenat Diagn 2013: 33: 707–710.
7. Rose NC, Benn P, Milunsky A. Current controversies in prenatal diagnosis 1: should NIPT routinely include microdeletions/microduplications? Prenat Diagn 2016: 36: 10–14.
8. Hui L. Cell-free DNA testing for 22q11.2 deletion syndrome: appraising the viability, effectiveness and appropriateness of screening. Ultrasound Obstet Gynecol 2016: 47: 137–141.
9. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008: 105: 16266–16271.
10. Chiu RW, Chan KC, Gao Y et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008: 105: 20458–20463.
11. Benn P, Cuckle H. Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma. Prenat Diagn 2014: 34: 778–783.
12. Fan HC, Quake SR. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS One 2010: 5: e10439.
13. Chu T, Yeniterzi S, Rajkovic A et al. High resolution non-invasive detection of a fetal microdeletion using the GCREM algorithm. Prenat Diagn 2014: 34: 469–477.
14. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013: 92: 167–176.
15. Lo KK, Karampetsou E, Boustred C et al. Limited clinical utility of non-invasive prenatal testing for subchromosomal abnormalities. Am J Hum Genet 2016: 98: 34–44.
16. Yu SC, Jiang P, Choy KW et al. Noninvasive prenatal molecular karyotyping from maternal plasma. PloS One 2013: 8: e60968.
17. Straver R, Sistermans EA, Holstege H, Visser A, Oudejans CB, Reinders MJ. WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme. Nucleic Acids Res 2014: 42: e31.
18. Bayindir B, Dehaspe L, Brison N et al. Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management. Eur J Hum Genet 2015: 23: 1286–1293.
19. Zhao C, Tynan J, Ehrich M et al. Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma. Clin Chem 2015: 61: 608–616.
20. Rampasek L, Arbabi A, Brudno M. Probabilistic method for detecting copy number variation in a fetal genome using maternal plasma sequencing. Bioinformatics 2014: 30: i212–i218.
21. Chen S, Lau TK, Zhang C et al. A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn 2013: 33: 584–590.
22. Li R, Wan J, Zhang Y et al. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies. Ultrasound Obstet Gynecol 2016: 47: 53–57.
23. Yatsenko SA, Peters DG, Saller DN, Chu T, Clemens M, Rajkovic A. Maternal cell-free DNA-based screening for fetal microdeletion and the importance of careful diagnostic follow-up. Genet Med 2015: 17: 836–838.
24. Sparks AB, Wang ET, Struble CA et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012: 32: 3–9.
25. Juneau K, Bogard PE, Huang S et al. Microarray-based cell-free DNA analysis improves noninvasive prenatal testing. Fetal Diagn Ther 2014: 36: 282–286.
26. Zimmermann B, Hill M, Gemelos G et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012: 32: 1233–1241.
27. Wapner RJ, Babiarz JE, Levy B et al. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. American journal of obstetrics and gynecology 2015: 212: e331–e339.
28. Benn P. Prenatal diagnosis of chromosomal abnormalities through chorionic villus sampling and amniocentesis. In: Milunsky A, Milunsky JM, eds. Genetic Disorders and the Fetus : Diagnosis, Prevention, and Treatment. Hoboken, NJ: John Wiley & Sons, Inc., 2016: 178–266.
29. Liehr T, Weise A. Frequency of small supernumerary marker chromosomes in prenatal, newborn, developmentally retarded and infertility diagnostics. Int J Mol Med 2007: 19: 719–731.
30. Wellesley D, Dolk H, Boyd PA et al. Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe. Eur J Hum Genet 2012: 20: 521–526.
31. Ferguson-Smith MA, Yates JR. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative european study on 52 965 amniocenteses. Prenat Diagn 1984: 4: 5–44.
32. Forabosco A, Percesepe A, Santucci S. Incidence of non-age-dependent chromosomal abnormalities: a population-based study on 88965 amniocenteses. Eur J Hum Genet 2009: 17: 897–903.
33. Baena N, De Vigan C, Cariati E et al. Prenatal detection of rare chromosomal autosomal abnormalities in Europe. Am J Med Genet A 2003: 118A: 319–327.
34. Ledbetter DH, Zachary JM, Simpson JL et al. Cytogenetic results from the U.S. Collaborative Study on CVS. Prenat Diagn 1992: 12: 317–345.
35. Association of Clinical Cytogeneticists Working Party on Chorionic Villi in Prenatal Diagnosis. Cytogenetic analysis of chorionic villi for prenatal diagnosis: an ACC collaborative study of U.K. data. Prenat Diagn 1994: 14: 363–379.
36. Malvestiti F, Agrati C, Grimi B et al. Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis. Prenat Diagn 2015: 35: 1117–1127.
37. Grati FR, Malvestiti F, Ferreira JC et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med 2014: 16: 620–624.
38. Snyder MW, Gammill HS, Shendure J. Copy-number variation and false positive results of prenatal screening. N Engl J Med 2015: 373: 2585.
39. Meschino WS, Miller K, Bedford HM. Incidental detection of familial APP duplication: an unusual reason for a false positive NIPT result of trisomy 21. Prenat Diagn 2016: 36: 382–384.
40. Snyder HL, Curnow KJ, Bhatt S, Bianchi DW. Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: implications for management and counseling. Prenat Diagn 2016: 36: 203–209.
41. Amant F, Verheecke M, Wlodarska I et al. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol 2015: 1: 814–819.
42. Bianchi DW, Chudova D, Sehnert AJ et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 2015: 314: 162–169.
43. Gromminger S, Yagmur E, Erkan S et al. Fetal aneuploidy detection by cell-free DNA sequencing for multiple pregnancies and quality issues with vanishing twins. J Clin Med 2014: 3: 679–692.
44. Wapner RJ, Martin CL, Levy B et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012: 367: 2175–2184.
45. Grati FR, Molina Gomes D, Ferreira JC et al. Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenat Diagn 2015: 35: 801–809.
46. McDonald-McGinn DM, Emanuel BS, Zackai EH. 22q11.2 deletion syndrome. In: Pagon RA, Adam MP, Ardinger HH, et al., eds. GeneReviews. Seattle, WA: University of Washington, 1993.
47. Donnelly JC, Platt LD, Rebarber A, Zachary J, Grobman WA, Wapner RJ. Association of copy number variants with specific ultrasonographically detected fetal anomalies. Obstet Gynecol 2014: 124: 83–90.
48. Liang D, Lv W, Wang H et al. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenat Diagn 2013: 33: 409–415.
49. Sehnert AJ, Rhees B, Comstock D et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011: 57: 1042–1049.
50. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012: 119: 890–901.
51. Peters D, Chu T, Yatsenko SA et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med 2011: 365: 1847–1848.
52. Jensen TJ, Dzakula Z, Deciu C, van den Boom D, Ehrich M. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem 2012: 58: 1148–1151.
53. Lefkowitz RB, Tynan JA, Liu T et al. Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. Am J Obstet Gynecol 2016 Feb 17. pii: S0002-9378(16)00318-5. doi: 10.1016/j.ajog.2016.02.030. [Epub ahead of print].
54. Gross SJ, Ryan A, Benn P. Noninvasive prenatal testing for 22q11.2 deletion syndrome: deeper sequencing increases the positive predictive value. Am J Obstet Gynecol 2015: 213: 254–255.
55. Sahoo T, Hovanes K, Strecker MN, Dzidic N, Commander S, Travis MK. Expanding noninvasive prenatal testing to include microdeletions and segmental aneuploidy: cause for concern? Genet Med 2016: 18: 275–276.
56. Helgeson J, Wardrop J, Boomer T et al. Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing. Prenat Diagn 2015: 35: 999–1004.
57. Gross SJ, Stosic M, McDonald-McGinn DM et al. Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome. Ultrasound Obstet Gynecol 2016: 47: 177–183.
58. Wald NLN. Antenatal and Neonatal Screening. Oxford: Oxford University Press, 2000.
59. Lau TK, Jiang FM, Stevenson RJ et al. Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service. Prenat Diagn 2013: 33: 602–608.
60. Ma J, Cram DS, Zhang J, Shang L, Yang H, Pan H. Birth of a child with trisomy 9 mosaicism syndrome associated with paternal isodisomy 9: case of a positive noninvasive prenatal test result unconfirmed by invasive prenatal diagnosis. Mol Cytogenet 2015: 8: 44.
61. Wang T, Duan C, Shen C et al. Detection of complex deletions in chromosomes 13 and 21 in a fetus by noninvasive prenatal testing. Mol Cytogenet 2016: 9: 3.
62. Milunsky JM. Prenatal diagnosis of sex chromosome abnormalities. In: Milunsky A, Milunsky JM, eds. Genetic Disorders and the Fetus : Diagnosis, Prevention, and Treatment. Hoboken, NJ: John Wiley & Sons, Inc., 2016: 267–312.
63. Benn P. Posttest risk calculation following positive noninvasive prenatal screening using cell-free DNA in maternal plasma. Am J Obstet Gynecol 2016: 214: 676e1-7.
64. Sullivan KE, Burrows E, McDonald McGinn DM. Healthcare utilization in chromosome 22q11.2 deletion patients with cardiac disease and low T cell counts. Am J Med Genet A 2016: 170: 1630–1634.
65. Kaimal AJ, Norton ME, Kuppermann M. Prenatal testing in the genomic age: clinical outcomes, quality of life, and costs. Obstet Gynecol 2015: 126: 737–746.
66. Committee Opinion No. 640. Cell-free DNA screening for fetal aneuploidy. Obstet Gynecol 2015: 126: e31–e37.
67. Dondorp W, de Wert G, Bombard Y et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet 2015: 23: 1438–1450.
68. Benn P, Borrell A, Chiu RW et al. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2015: 35: 725–734.
69. Norton ME, Jelliffe-Pawlowski LL, Currier RJ. Chromosome abnormalities detected by current prenatal screening and noninvasive prenatal testing. Obstet Gynecol 2014: 124: 979–986.
70. Foster MW, Mulvihill JJ, Sharp RR. Evaluating the utility of personal genomic information. Genet Med 2009: 11: 570–574.
71. Hook EB, Cross PK, Jackson L, Pergament E, Brambati B. Maternal age-specific rates of 47,+21 and other cytogenetic abnormalities diagnosed in the first trimester of pregnancy in chorionic villus biopsy specimens: comparison with rates expected from observations at amniocentesis. Am J Hum Genet 1988: 42: 797–807.
72. Hook EB, Cross PK. Maternal age-specific rates of chromosome abnormalities at chorionic villus study: a revision. Am J Hum Genet 1989: 45: 474–477.
73. Leschot NJ, Wolf H, Van Prooijen-Knegt AC et al. Cytogenetic findings in 1250 chorionic villus samples obtained in the first trimester with clinical follow-up of the first 1000 pregnancies. Br J Obstet Gynaecol 1989: 96: 663–670.
74. Kratzer PG, Golbus MS, Schonberg SA, Heilbron DC, Taylor RN. Cytogenetic evidence for enhanced selective miscarriage of trisomy 21 pregnancies with advancing maternal age. Am J Med Genet 1992: 44: 657–663.
75. Snijders RJ, Holzgreve W, Cuckle H, Nicolaides KH. Maternal age-specific risks for trisomies at 9–14 weeks' gestation. Prenat Diagn 1994: 14: 543–552.
76. Yin AH, Peng CF, Zhao X et al. Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA. Proc Natl Acad Sci USA 2015: 112: 14670–14675.
77. Jensen TJ, Zwiefelhofer T, Tim RC et al. High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma. PLoS One 2013: 8: e57381.